ALTHE — Theraclion SA Share News
0.000.00%
Last trade - 00:00- €41.86m
- €43.43m
- €1.19m
Brief: Theraclion Puts In Place Equity Financing Of 3.6 Million Euros
Brief: Theraclion Completes First Varicose Veins Study
Brief: Theraclion Commercial Agreement Secured With Diagnostikum Berlin
Brief: Theraclion First Veterinary Patient Cancer Free After Treatment With Echopulse
Brief: Theraclion's Echopulse: Positive Preliminary Results From Ongoing Trial Of First Non-Invasive Approach To Treatment Of Varicose Veins Of Lower Limb
Brief: Theraclion Accelerates Its Sales And Clinical Development In Asia
Brief: Theraclion FY Net Loss Narrows To 6.2 Million Euros
Brief: Theraclion Sells First Echopulse System To Catalonia, Spain
Brief: Theraclion FY Revenue Increases To 2.4 Million Euros
Brief: First Patient Treatments By Theraclion'S Echopulse In Poland
Brief: Theraclion Achieves Two Sales From Russia And Eastern Europe
Brief: Theraclion to present data from the U.S. pilot trial of echotherapy with Echopulse
Brief: Theraclion presents preliminary results of echotherapy
Brief: Theraclion announces progress towards market access for Echopulse in the U.S.
Brief: Theraclion raises 4.2 million euros through private placement
Brief: Theraclion announces exclusive distribution agreement with EDAP TMS France
Brief: Theraclion H1 net operating loss widens to 4.2 million euros
lead investigator discuss clinical trial combining echotherapy and imunotherapy to treat metastatic breast cancer
Brief: Theraclion publishes clinical trial results